Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.230
Neutral
RSI(14)
45.358
Neutral
STOCH(KDJ)(9,3,3)
72.013
Neutral
ATR(14)
0.327
High Vlolatility
CCI(14)
39.980
Neutral
Williams %R
29.771
Buy
TRIX(12,20)
-0.152
Sell
StochRSI(14)
12.941
Sell
Fresenius Medical Care AG
FMS23.515USD
+0.035+0.15%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
6.82BMarket Cap
17.30P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Fresenius Medical Care AG
Currency: USD Updated: 2025-12-19Key Insights
Fresenius Medical Care AG's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 47/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 28.05.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fresenius Medical Care AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Hold
Current Rating
28.046
Target Price
+22.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Fresenius Medical Care AG Highlights
StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 17.30, at a low 3-year percentile range.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 155.10K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Fresenius Medical Care AG is 8.98, ranking 10/78 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.71B, representing a year-over-year increase of 9.17%, while its net profit experienced a year-over-year increase of 37.23%.
Score
Financials
6.50
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.42
Operational Efficiency
9.31
Growth Potential
10.00
Shareholder Returns
9.68
Fresenius Medical Care AG's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Fresenius Medical Care AG is 6.28, ranking 59/78 in the Healthcare Providers & Services industry. Its current P/E ratio is 17.30, which is 52.59% below the recent high of 26.39 and 22.85% above the recent low of 13.34.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 47/78
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Fresenius Medical Care AG is 5.14, ranking 68/78 in the Healthcare Providers & Services industry. The average price target for Fresenius Medical Care AG is 28.00, with a high of 39.65 and a low of 20.70.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
28.046
Target Price
+22.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
65
Total
7
Median
9
Average
Company name
Ratings
Analysts
Fresenius Medical Care AG
FMS
7
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Fresenius Medical Care AG is 6.98, ranking 45/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 24.26 and the support level at 22.69, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
23.600
Sell
MA10
23.388
Buy
MA20
23.520
Sell
MA50
24.731
Sell
MA100
25.010
Sell
MA200
25.733
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Fresenius Medical Care AG is 3.00, ranking 60/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 8.10%, representing a quarter-over-quarter decrease of 0.22%. The largest institutional shareholder is Richard Pzena, holding a total of 14.82M shares, representing 2.56% of shares outstanding, with 2.46% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Wellington Management Company, LLP
Fiduciary Management, Inc.
Todd Asset Management LLC
Aristotle Capital Management, LLC
Parametric Portfolio Associates LLC
Morgan Stanley & Co. International Plc
Janus Henderson Investors
Kentucky Teachers' Retirement System
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Fresenius Medical Care AG is 8.07, ranking 14/78 in the Healthcare Providers & Services industry. The company's beta value is 0.89. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.89
VaR
+3.01%
240-Day Maximum Drawdown
+24.32%
240-Day Volatility
+29.27%
Return
Best Daily Return
60 days
+3.63%
120 days
+3.63%
5 years
+11.19%
Worst Daily Return
60 days
-7.82%
120 days
-7.82%
5 years
-17.57%
Sharpe Ratio
60 days
-1.42
120 days
-1.55
5 years
-0.05
Risk Assessment
Maximum Drawdown
240 days
+24.32%
3 years
+40.49%
5 years
+69.59%
Return-to-Drawdown Ratio
240 days
+0.13
3 years
+0.18
5 years
-0.10
Skewness
240 days
-0.47
3 years
-0.76
5 years
-0.81
Volatility
Realised Volatility
240 days
+29.27%
5 years
+31.73%
Standardised True Range
240 days
+2.15%
5 years
+2.19%
Downside Risk-Adjusted Return
120 days
-194.64%
240 days
-194.64%
Maximum Daily Upside Volatility
60 days
+23.21%
Maximum Daily Downside Volatility
60 days
+25.92%
Liquidity
Average Turnover Rate
60 days
+0.11%
120 days
+0.13%
5 years
--
Turnover Deviation
20 days
-20.05%
60 days
-18.29%
120 days
+1.53%
Peer Comparison
Healthcare Providers & Services
Fresenius Medical Care AG
FMS
6.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
ALHC
8.83 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chemed Corp
CHE
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
LFST
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
OPCH
8.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Fresenius Medical Care AG?
The TradingKey Stock Score provides a comprehensive assessment of Fresenius Medical Care AG based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Fresenius Medical Care AG’s performance and outlook.
How do we generate the financial health score of Fresenius Medical Care AG?
To generate the financial health score of Fresenius Medical Care AG, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Fresenius Medical Care AG's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Fresenius Medical Care AG.
How do we generate the company valuation score of Fresenius Medical Care AG?
To generate the company valuation score of Fresenius Medical Care AG, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Fresenius Medical Care AG’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Fresenius Medical Care AG’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Fresenius Medical Care AG.
How do we generate the earnings forecast score of Fresenius Medical Care AG?
To calculate the earnings forecast score of Fresenius Medical Care AG, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Fresenius Medical Care AG’s future.
How do we generate the price momentum score of Fresenius Medical Care AG?
When generating the price momentum score for Fresenius Medical Care AG, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Fresenius Medical Care AG’s prices. A higher score indicates a more stable short-term price trend for Fresenius Medical Care AG.
How do we generate the institutional confidence score of Fresenius Medical Care AG?
To generate the institutional confidence score of Fresenius Medical Care AG, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Fresenius Medical Care AG’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Fresenius Medical Care AG.
How do we generate the risk management score of Fresenius Medical Care AG?
To assess the risk management score of Fresenius Medical Care AG, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Fresenius Medical Care AG’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Fresenius Medical Care AG.
